RVNC
Victory Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,788
| Closed | -$35.8K | – | 2539 |
|
|
2024
Q4 | $35.8K | Sell |
11,788
-285
| -2% | -$866 | ﹤0.01% | 2418 |
|
|
2024
Q3 | $62.7K | Sell |
12,073
-236
| -2% | -$1.23K | ﹤0.01% | 2373 |
|
|
2024
Q2 | $31.6K | Buy |
12,309
+1,908
| +18% | +$4.9K | ﹤0.01% | 2398 |
|
|
2024
Q1 | $51.2K | Sell |
10,401
-153
| -1% | -$753 | ﹤0.01% | 2376 |
|
|
2023
Q4 | $92.8K | Buy |
+10,554
| New | +$92.8K | ﹤0.01% | 2354 |
|
|
2023
Q3 | – | Sell |
-564,355
| Closed | -$14.3M | – | 2571 |
|
|
2023
Q2 | $14.3M | Sell |
564,355
-34,330
| -6% | -$869K | 0.02% | 904 |
|
|
2023
Q1 | $19.3M | Buy |
598,685
+567,555
| +1,823% | +$18.3M | 0.02% | 798 |
|
|
2022
Q4 | $575K | Sell |
31,130
-9,410
| -23% | -$174K | ﹤0.01% | 1960 |
|
|
2022
Q3 | $1.09M | Buy |
+40,540
| New | +$1.09M | ﹤0.01% | 1694 |
|
|
2021
Q4 | – | Sell |
-9,482
| Closed | -$264K | – | 2862 |
|
|
2021
Q3 | $264K | Sell |
9,482
-436
| -4% | -$12.1K | ﹤0.01% | 2425 |
|
|
2021
Q2 | $294K | Sell |
9,918
-284
| -3% | -$8.42K | ﹤0.01% | 2424 |
|
|
2021
Q1 | $285K | Buy |
10,202
+391
| +4% | +$10.9K | ﹤0.01% | 2415 |
|
|
2020
Q4 | $278K | Buy |
9,811
+483
| +5% | +$13.7K | ﹤0.01% | 2302 |
|
|
2020
Q3 | $235K | Buy |
+9,328
| New | +$235K | ﹤0.01% | 2246 |
|
|
2020
Q2 | – | Sell |
-15,966
| Closed | -$236K | – | 3368 |
|
|
2020
Q1 | $236K | Buy |
15,966
+6,119
| +62% | +$90.4K | ﹤0.01% | 2294 |
|
|
2019
Q4 | $160K | Buy |
9,847
+3,508
| +55% | +$57K | ﹤0.01% | 2376 |
|
|
2019
Q3 | $82K | Buy |
+6,339
| New | +$82K | ﹤0.01% | 2501 |
|
|
2018
Q3 | – | Sell |
-59,245
| Closed | -$1.63M | – | 1904 |
|
|
2018
Q2 | $1.63M | Sell |
59,245
-3,300
| -5% | -$90.6K | ﹤0.01% | 1122 |
|
|
2018
Q1 | $1.93M | Buy |
62,545
+6,860
| +12% | +$211K | ﹤0.01% | 1079 |
|
|
2017
Q4 | $1.99M | Buy |
55,685
+20,970
| +60% | +$750K | ﹤0.01% | 1037 |
|
|
2017
Q3 | $956K | Sell |
34,715
-160
| -0.5% | -$4.41K | ﹤0.01% | 1221 |
|
|
2017
Q2 | $921K | Sell |
34,875
-650
| -2% | -$17.2K | ﹤0.01% | 1205 |
|
|
2017
Q1 | $739K | Buy |
+35,525
| New | +$739K | ﹤0.01% | 1235 |
|